Home  >  News
Eppen_Himac_Jan25
Waters_Ebook_Dec24
you can get e-magazine links on WhatsApp. Click here
News
  DFE Pharma expands its C2F Center of Excellence in Hyderabad to advance the development of critical respiratory treatments,   January 14, 2025
  Aragen secures $100 million investment from Quadria Capital,   January 13, 2025
  Neuberg Diagnostics secures an investment of Rs. 940 crore from Kotak Alt,   January 10, 2025
  Lupin’s ivacaftor oral granules receives US FDA tentative approval,   January 10, 2025
  Lupin receives US FDA tentative approval for loteprednol etabonate ophthalmic gel,   January 09, 2025
  Lilly to establish new global capability centre in Hyderabad, India to hire over 1,000 skilled teams,   January 09, 2025
  Sun Pharma launches Entrepreneurship Development Programme to empower women in Vadodara,   January 09, 2025
  Lupin’s Pithampur Unit-1 facility gets EIR from US FDA with VAI classification,   January 09, 2025
  Botanic Healthcare raises Rs. 250 crore to drive global expansion and market leadership,   January 08, 2025
  Zydus enters agreement with CVS Caremark to add Zituvio, Zituvimet and Zituvimet XR to its template formulary,   January 07, 2025
  CRIUS Group adopts 100%AI-based project implementation,   January 07, 2025
  Sun Pharma inaugurates Training-Cum-Production Centre to empower women in Jammu,   January 07, 2025
  CIPI chairman says the pharma MSME sector had expected unconditional extension and financial aid from the government,   January 06, 2025
  Veeda Group rebrands as ‘Veeda Lifesciences’,   January 02, 2025
  Anthem Biosciences files DRHP for Rs. 3,395 crore IPO,   January 02, 2025
  Lupin acquires Huminsulin from Lilly to enhance diabetes portfolio,   December 31, 2024
  Waters Corporation named to Dow Jones Sustainability Index for the fourth consecutive year,   December 27, 2024
  Venus Remedies partners with NSDC to pioneer workforce development through skill certification,   December 24, 2024
  GangaGen secures additional US$ 7.9 million from CARB-X for pre-clinical development multidrug-resistant Klebsiella pneumoniae,   December 23, 2024
  Senores Pharmaceuticals’ IPO to close on December 24, 2024, price band set at Rs. 372/- to Rs. 391/- per equity share,   December 23, 2024

  • Results Found: 12712
  • 1
    •  
  • 2
    •  
  • 3
    •  
  • 4
    •  
  • 5
    •  
  • Go to
  • Total Number of Pages: 636
 Back
 
Asia_Lab_Expo2025
chemexpoindia
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram